THERAPEUTIC AGENT FOR NOCTURNAL POLLAKIURIA

Title:

THERAPEUTIC AGENT FOR NOCTURNAL POLLAKIURIA

Document Type and Number:

WIPO Patent Application WO/2019/124507

Kind Code:

A1

Abstract:

[Problem] To provide a novel therapeutic agent for nocturnal pollakiuria. [Solution] A therapeutic agent for nocturnal pollakiuria which contains, as an active ingredient, (6S)-N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide.

Inventors:

SEGAWA KATSUYA (JP)
KUROSE TAKAFUMI (JP)

Application Number:

PCT/JP2018/047038

Publication Date:

June 27, 2019

Filing Date:

December 20, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

KYORIN SEIYAKU KK (JP)
KISSEI PHARMACEUTICAL (JP)

International Classes:

A61K31/519; A61P13/10; A61P43/00

Domestic Patent References:

WO2009124167A1	2009-10-08
WO2004078163A2	2004-09-16

Foreign References:

JP2011510023A

2011-03-31

Other References:

NITTI, V. ET AL.: "Results of a Randomized Phase III Trial of Mirabegron in Patients with Overactive Bladder", J UROL., vol. 189, no. 4, 1 April 2013 (2013-04-01), pages 1388 - 1395, XP055620059, ISBN: 0022-5347, DOI: 10.1016/j.juro.2012.10.017
NEUROUROL URODYN, vol. 23, 2004, pages 302 - 305
NEUROUROLOGY AND URODYNAMICS, vol. 34, no. 7, 2015, pages 685 - 692
BJU INTERNATIONAL, vol. 113, no. 6, 2014, pages 951 - 960
INTERNATIONAL JOURNAL OF UROLOGY, vol. 21, no. 10, 2014, pages 960 - 967
NEUROUROLOGY AND URODYNAMICS, vol. 32, no. 8, 2013, pages 1116 - 1122
JOURNAL OF UROLOGY, vol. 189, no. 4, 2013, pages 1388 - 1395
EUR. UROL. SUPPL., vol. 5, 2006, pages 3 - 11
SLEEP, vol. 14, 1991, pages 294 - 306
See also references of EP 3730141A4

Attorney, Agent or Firm:

MIZUNO, Katsufumi et al. (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: ORGANIC SEMICONDUCTOR INK ADMIXED WITH MATERIAL THAT ASSISTS CHARGE INJECTION

Next Patent: WIRE SHAPE INSPECTING DEVICE AND WIRE SHAPE INSPECTING METHOD